RIPK2 and breast cancer: Significant, nonrandom differences in expression distribution across the 10 METABRIC datasets was seen for 40 of the 47 genes, with several genes (for example, RIPK2, EFNA4 and TMEM9B) differentially expressed in breast cancer subtypes with high proliferation.